Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Change in Accured Expenses: 2018-2019

Historic Change in Accured Expenses for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to $227,000.

  • DiaMedica Therapeutics' Change in Accured Expenses rose 176.69% to $227,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $226,000, marking a year-over-year decrease of 43.78%. This contributed to the annual value of $2.5 million for FY2024, which is 615.23% up from last year.
  • Latest data reveals that DiaMedica Therapeutics reported Change in Accured Expenses of $227,000 as of Q4 2019, which was up 16.41% from $195,000 recorded in Q3 2019.
  • In the past 5 years, DiaMedica Therapeutics' Change in Accured Expenses ranged from a high of $409,000 in Q3 2018 and a low of -$296,000 during Q4 2018.
  • Over the past 2 years, DiaMedica Therapeutics' median Change in Accured Expenses value was $119,500 (recorded in 2018), while the average stood at $78,500.
  • Examining YoY changes over the last 5 years, DiaMedica Therapeutics' Change in Accured Expenses showed a top increase of 176.69% in 2019 and a maximum decrease of 256.82% in 2019.
  • DiaMedica Therapeutics' Change in Accured Expenses (Quarterly) stood at -$296,000 in 2018, then surged by 176.69% to $227,000 in 2019.
  • Its Change in Accured Expenses stands at $227,000 for Q4 2019, versus $195,000 for Q3 2019 and -$69,000 for Q2 2019.